These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 21944943)

  • 1. Monoclonal antibodies for the treatment of asthma.
    Catley MC; Coote J; Bari M; Tomlinson KL
    Pharmacol Ther; 2011 Dec; 132(3):333-51. PubMed ID: 21944943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agents against cytokine synthesis or receptors.
    Yamagata T; Ichinose M
    Eur J Pharmacol; 2006 Mar; 533(1-3):289-301. PubMed ID: 16457805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies for chronic refractory asthma and pipeline developments.
    Polosa R; Casale T
    Drug Discov Today; 2012 Jun; 17(11-12):591-9. PubMed ID: 22306350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases.
    D'Amato G
    Eur J Pharmacol; 2006 Mar; 533(1-3):302-7. PubMed ID: 16464445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical safety and pharmacology of an anti-human interleukin-13 monoclonal antibody in normal macaques and in macaques with allergic asthma.
    Martin PL; Fisher D; Glass W; O'Neil K; Das A; Martin EC; Li L
    Int J Toxicol; 2008; 27(5):351-8. PubMed ID: 19037805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma].
    Michils A; Sternon J
    J Pharm Belg; 2006; 61(3):83-7. PubMed ID: 17058881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of monoclonal antibodies in the treatment of severe asthma.
    Tourangeau LM; Kavanaugh A; Wasserman SI
    Ther Adv Respir Dis; 2011 Jun; 5(3):183-94. PubMed ID: 21393345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin E blockade in the treatment of asthma.
    Kuhn R
    Pharmacotherapy; 2007 Oct; 27(10):1412-24. PubMed ID: 17896896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging drugs for asthma.
    Quirce S; Bobolea I; Barranco P
    Expert Opin Emerg Drugs; 2012 Jun; 17(2):219-37. PubMed ID: 22607631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-IgE and other antibody targets in asthma.
    Singh J; Kraft M
    Handb Exp Pharmacol; 2008; (181):257-88. PubMed ID: 18071950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient stratification and the unmet need in asthma.
    Swedin L; Saarne T; Rehnberg M; Glader P; Niedzielska M; Johansson G; Hazon P; Catley MC
    Pharmacol Ther; 2017 Jan; 169():13-34. PubMed ID: 27373855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pneumology. Anti-IgE antibodies in the treatment of asthma].
    Leuenberger P; Sauty A; Rochat T
    Rev Med Suisse; 2007 Jan; 3(93):56-9. PubMed ID: 17354662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-immunoglobulin E therapy with omalizumab for asthma.
    Hendeles L; Sorkness CA
    Ann Pharmacother; 2007 Sep; 41(9):1397-410. PubMed ID: 17698897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab.
    Nowak D
    Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for phenotype-driven treatment in asthmatic patients.
    Gonem S; Desai D; Siddiqui S; Brightling CC
    Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):381-5. PubMed ID: 21670666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-IgE in severe persistent allergic asthma.
    Fox H
    Respirology; 2007 Nov; 12 Suppl 3():S22-8; discussion S45-7. PubMed ID: 17956516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omalizumab for severe asthma?
    Drug Ther Bull; 2006 Nov; 44(11):86-8. PubMed ID: 17089921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma.
    Noga O; Hanf G; Brachmann I; Klucken AC; Kleine-Tebbe J; Rosseau S; Kunkel G; Suttorp N; Seybold J
    J Allergy Clin Immunol; 2006 Jun; 117(6):1493-9. PubMed ID: 16751018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.
    Hart TK; Cook RM; Zia-Amirhosseini P; Minthorn E; Sellers TS; Maleeff BE; Eustis S; Schwartz LW; Tsui P; Appelbaum ER; Martin EC; Bugelski PJ; Herzyk DJ
    J Allergy Clin Immunol; 2001 Aug; 108(2):250-7. PubMed ID: 11496242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel cytokine-directed therapies for asthma.
    Walsh GM
    Discov Med; 2011 Apr; 11(59):283-91. PubMed ID: 21524382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.